Condition · ICD-10 E10.9

Type 1 Diabetes

Insulin-Dependent Diabetes

An autoimmune condition in which the immune system destroys insulin-producing beta cells in the pancreas, requiring lifelong insulin therapy.

Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency. It requires lifelong insulin therapy for survival. Intensive insulin regimens (basal-bolus) or insulin pump therapy combined with continuous glucose monitoring are the standards of modern management to minimize complications.

At a glance
Medications tracked
6
First-line options
Insulin Glargine, Insulin Aspart, Insulin Lispro, Insulin Detemir
Related conditions
Type 2 DiabetesCeliac DiseaseHypothyroidismPeripheral Neuropathy

First-line Related Treatments

Commonly associated primary options — verify with your clinician

Primary options
Insulin Glargine
Insulin Glargine
Rx
Injection
Strength 100 units/mL
NDC 0088-2220-33
Insulin Aspart
Insulin Aspart
Rx
Injection
Strength 100 units/mL
NDC 0169-7501-11
Insulin Lispro
Insulin Lispro
Rx
Injection
Strength 100 units/mL
NDC 0002-7510-01
Insulin Detemir
Insulin Detemir
Rx
Injection
Strength 100 units/mL
NDC 0169-3687-12

Situational

Related options for specific presentations

Specific presentations
Glucagon
Glucagon
Rx
Kit
Strength 1 mg
NDC 0002-7486-01
Pramlintide Acetate
Pramlintide Acetate
Rx
Injection
Strength 0.6 mg/mL
NDC 0089-6090-20

Top treatments tried for Type 1 Diabetes

Community-driven data · early preview

Insulin Glargine
1,800 people tried
4.3
Insulin Aspart
1,520 people tried
4.1
Insulin Lispro
1,240 people tried
4.0
Insulin Detemir
960 people tried
3.8
Help build the dataset — log treatments you've tried, rate what helped, and report side effects.